Yvette Fairfax: Wiskott-Aldrich Gene Therapy Changes Immunity, but Affordability May Determine Survival
Yvette Fairfax, Shareholder of KOELIS, shared a post on LinkedIn:
“The approval of the first gene therapy for Wiskott-Aldrich syndrome is a profound milestone for families facing a disorder linked to immune dysfunction, bleeding risk, and repeated infections.
For affected children, this kind of therapy is not just an incremental medical improvement. It has the potential to reduce hospital crises, improve stability, and reshape daily life in a much more fundamental way.But the controversy begins right after celebration.
Gene therapies often represent the best of science and the hardest realities of healthcare economics at the same time. A breakthrough can be medically transformative and still remain financially out of reach for families trapped in slow reimbursement systems or unequal access pathways.
In the U.S., UK, and Canada, rare-disease medicine keeps exposing the same structural tension: scientific innovation moves faster than fair access. If a one-time treatment can prevent years of suffering, complications, and repeated medical costs, waiting too long to fund it may be both unjust and inefficient.
Should public systems approve payment earlier for these therapies instead of forcing families through exhausting access battles first?”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 22:59Building Effective Patient Advocacy Through Collaboration Between Patients and Clinicians – EHC
-
Oct 20, 2026, 21:22Intezar Mehdi: When Prolonged Bleeding May Indicate an Underlying Bleeding Disorder
-
Oct 20, 2026, 21:06Nandini Pethe: Sharing My Experience as a Caregiver in the HOPE Factor Resource Guide
-
Oct 20, 2026, 16:51Suzan Nakasendwa: A Growing Stroke Challenge in Uganda
-
Oct 20, 2026, 16:38Steve Moon: How Does Smoking Cessation Duration Affect Ischemic Stroke Risk
-
Oct 20, 2026, 16:25Cedrice Mentor: Reducing Platelet Wastage Through Cold Storage
-
Oct 20, 2026, 16:09Thirunavukkarasu Angappan: Can a Purified Fibrinogen Concentrate Replace Cryoprecipitate
-
Oct 20, 2026, 16:01Kalyan Roy: Platelet Conservation Through Evidence-Based Transfusion Practice
-
Oct 20, 2026, 15:28Stacy E. Croteau: 33 Countries, One Mission – Better Bleeding Disorder Care